Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Pasternak-Wise

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Seminars in Interventional Radiology|December 12, 2024
Percutaneous CT-Guided Deep Neck AccessCaleb VanDyke, Olga Pasternak-Wise, Edward A Michals, et al.
Head and Neck Pathology|April 20, 2026
High-Grade Acinic Cell Carcinoma of the Parotid with SYN2::PPARG FusionAndrii Puzyrenko, Prokopios P Argyris, Olga Pasternak-Wise, et al.
JAMA Network Open|April 13, 2022
Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal CarcinomaVivek Nair, Samuel Auger, Sara Kochanny, et al.
JAMA Oncology|March 6, 2025
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical TrialAri J Rosenberg, Aditya Juloori, Michael J Jelinek, et al.
JAMA Oncology|June 6, 2024
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled TrialAri J Rosenberg, Nishant Agrawal, Aditya Juloori, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Seminars in Interventional Radiology|December 12, 2024
Percutaneous CT-Guided Deep Neck AccessCaleb VanDyke, Olga Pasternak-Wise, Edward A Michals, et al.
Head and Neck Pathology|April 20, 2026
High-Grade Acinic Cell Carcinoma of the Parotid with SYN2::PPARG FusionAndrii Puzyrenko, Prokopios P Argyris, Olga Pasternak-Wise, et al.
JAMA Network Open|April 13, 2022
Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal CarcinomaVivek Nair, Samuel Auger, Sara Kochanny, et al.
JAMA Oncology|March 6, 2025
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical TrialAri J Rosenberg, Aditya Juloori, Michael J Jelinek, et al.
JAMA Oncology|June 6, 2024
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled TrialAri J Rosenberg, Nishant Agrawal, Aditya Juloori, et al.
Pageof 1